(Q43607225)

English

Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

stem cell transplantation

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Giuseppe Milone

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

7

object named as

Fabio Ciceri

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Luigi Rigacci

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Bendetta Puccini

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Pasquale Iacopino

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Stefania Bramanti

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Renato Fanin

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Alessandro Rambaldi

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Michele Falda

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Stefano Guidi

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Massimo Fabrizio Martelli

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Patrizio Mazza

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Rosi Oneto

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Gruppo Italiano Trapianto di Midollo Osseo (GITMO)

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

14 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Annals of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

91

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

931-939

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1395-9

21 January 2018

Rituximab versus observation after high-dose consolidative first-line chemotherapy with autologous stem-cell transplantation in patients with poor-risk diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1395-9

21 January 2018

Gene-marking to trace origin of relapse after autologous bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1395-9

21 January 2018

Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1395-9

21 January 2018

Allogeneic or autologous bone marrow transplantation (BMT) for non-Hodgkin's lymphoma (NHL): results of a provincial strategy. Ontario BMT Network, Canada.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1395-9

21 January 2018

The role of allogeneic transplantation in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1395-9

21 January 2018

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1395-9

21 January 2018

Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1395-9

21 January 2018

Allogeneic bone marrow transplantation for lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1395-9

21 January 2018

Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1395-9

21 January 2018

Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1395-9

21 January 2018

Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1395-9

21 January 2018

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1395-9

21 January 2018

Efficacy of reduced-intensity allogeneic stem cell transplantation in chemotherapy-refractory non-hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1395-9

21 January 2018

Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1395-9

21 January 2018

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1395-9

21 January 2018

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1395-9

21 January 2018

Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1395-9

21 January 2018

Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1395-9

21 January 2018

Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the Société Française de Greffe de Moelle et de Thérapie Cellu

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1395-9

21 January 2018

Identifiers

10.1007/S00277-011-1395-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22245922%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43607225&oldid=2101866445"